S&P 500 (SP500.US500)

Close: 5 525.21 (+40.44), Apr 25, 2025
Negative

Low risk

Automatic technical analysis. Short term, Apr 25, 2025

S&P 500 has broken the ceiling of the falling trend in the short term, which indicates a slower initial falling rate. The index is testing resistance at points 5530. This could give a negative reaction, but an upward breakthrough of points 5530 means a positive signal. RSI diverges positively against the price, which indicates a possibility for a reaction up. The index is overall assessed as technically negative for the short term.

Recommendation one to six weeks: Negative (Score: -54)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-0.71%0.00+0.74%
5 days0.002.37%0.00+4.59%
22 days0.006.00%0.00-4.35%
66 days0.0011.40%0.00-8.66%

More analyses of S&P 500

chart S&P 500 (SP500) Candlesticks 22 Days
Candlesticks
chart S&P 500 (SP500) Short term
Short term: Negative
chart S&P 500 (SP500) Medium term
Medium term: Weak Positive
chart S&P 500 (SP500) Long term
Long term: Weak Positive
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.